Nestec S.a.

Mead Johnson Nutrition Company

United States of America, As Represented by the Secretary of Agriculture

Hill's Pet Nutrition, Inc.

Clasado Inc.

Clasado Research Services Limited

University of Reading, School of Food Biosciences

Glenn R Gibson

Robert Rastall

Robert J McMahon

Anna-Marja Aura

Renia Gemmell

Maria Saarela

Robert J Mcmahon

Robert A Rastall

Bryon W Petschow

Georgios Tzortzis

Sofia Kolida

Kathy L Gross

Christina Khoo

Alberto Nunez

Jonathan Brostoff

Arland T Hotchkiss

Anthony G Wynne

Byron W Petschow

Jacek Witold Slupinski

Anthony Graham Wynne

Jonathan R Rhoades

Kathy Lynn Gross

The present invention provides a method for the prevention of the incidence of and/or a reduction in the duration of acute diarrhoea, particularly in travelers, said method comprising orally administering an oligosaccharide composition, in particular a non-digestible oligosaccharide, to a mammal.

Method of preventing diarrhoea

The present invention is directed to a novel method for increasing the production of acetate, decreasing the production of butyrate, increasing the population and species of beneficial bacteria and slowing the rate of fermentation of prebiotics within the gut of a formula-fed infant. The method comprises administration of a therapeutically effective amount of PDX to the infant.

Nutritional composition having prebiotic

A method of promoting the growth of beneficial bacteria in the gut of a human in need thereof, which involves administering to a human a composition containing an effective amount of Ara-(1-5)-(Ara)-(1-5)-Ara as a prebiotic, where n=0-18.

Methods of promoting the growth of beneficial bacteria in the gut

Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants

The present invention concerns nutritional compositions comprising oligosaccharides for controlling inflammatory bowel disease and related disorders, such as diarrhea and constipation.

Prebiotic compositions

Method for simulating the functional attributes of human milk oligosaccharides

Novel strains ofcapable of producing a novel galactosidase enzyme activity that converts lactose to a novel mixture of galactooligosaccharides. The mixture of oligosaccharidcs may be incorporated into numerous food products or animal feeds for improving gut health by promoting the growth of bifidobacteria in the gut, and repressing the growth of the pathogenic microflora.

Galactooligosaccharide composition and the preparation thereof

The present invention concerns compositions comprising a saccharide for the inhibition of pathogen adhesion to mammalian cells.

Compositions comprising oligosaccharides

A novel probiotic strain termedNCIMB 41114 is capable of preventing growth of pathogenic microorganisms in the GI tract. In particular, this bacterium inhibitsovergrowth, and can be employed to prevent and treat associated diseases, including IBS and thrush.

[object Object]

A method for reducing the quantity ofand/orspp. in the GI tract of a companion pet which comprises orally administering to the said pet aand/orspp. reducing quantity of a fiber or other component.

Composition and method

Growing community of inventors

Reading, United Kingdom

Glenn R Gibson